Investigation of PEMF Therapy for Female Patients With IC/BPS

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Nov 24, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called low-frequency pulsed electromagnetic field (PEMF) therapy for women suffering from Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). The goal is to find out if this non-drug therapy can help reduce bladder and pelvic pain, as well as other urinary symptoms linked to IC/BPS. Women aged between 18 and 75 who have a diagnosed case of IC/BPS and a pain score of 6 or higher may be eligible to participate. Participants will use the PEMF device over a period of 16 weeks, with data collected at several points to see how effective the therapy is.

If you choose to join the study, you will receive the PEMF device to use at home. The trial involves checking in at the start of the study, then again after 4 weeks, and later at 8, 12, and 16 weeks to assess your symptoms. However, there are specific criteria for participation; for instance, you cannot have certain medical conditions like cancer or active urinary infections, and you should not be pregnant. This trial is currently recruiting participants, and it offers a chance to explore a new treatment option that might improve your quality of life.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Previously established clinical diagnosis of IC/PS
• • Current numeric rating scale (NRS) score of ≥ 6
• • History of cystoscopy with hydrodistension with bladder capacity determination under anesthesia
• • No cognitive deficits
• Exclusion Criteria:
• • History of bladder, ovarian, vaginal cancer
• • History of urethral diverticulum
• • History of radiation cystitis
• • History of spinal cord injury or spina bifida
• • History of Parkinson's disease, multiple sclerosis, or stroke
• • Current placement of a pacemaker or metal prosthesis
• • Active urinary tract infection
• • BMI \> 40
• • Residual urine of \> 100cc
• • Current pregnant